Endexx Corporation (EDXC) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerEndexx Corporation (EDXC) trades at $0.0001. Endexx Corporation manufactures and sells cannabidiol (CBD)-based health and wellness products, including creams, oils, and pet products. The company operates primarily through its e-commerce site, cbdunlimited.com, and other online and in-store retailers. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for EDXC: EDXC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EDXC against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Dated analysis: the newest financial statements on file are 24 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
EDXC: the 2 scored disciplines are evenly split. Dominant signal: Seth Klarman bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Endexx Corporation (EDXC) Healthcare & Pipeline Overview
Endexx Corporation focuses on the cannabidiol (CBD) health and wellness market, offering a range of CBD-based products for humans and pets. Operating in the specialty and generic drug manufacturing sector, the company leverages its e-commerce platform and retail partnerships to distribute CBD creams, oils, and other health and beauty products.
What Is the Investment Thesis for EDXC?
Endexx Corporation presents a speculative investment opportunity within the burgeoning CBD market. With a negative P/E ratio of -0.00 and a high profit margin of 1181.3%, the company's financial metrics suggest potential volatility. Key value drivers include expanding its product line and increasing its distribution network. Growth catalysts involve capitalizing on the increasing acceptance and legalization of CBD products. Potential risks include intense competition, regulatory uncertainties, and the challenges of operating on the OTC market. Investors should carefully consider these factors when evaluating EDXC.
Based on FMP financials and quantitative analysis
EDXC Key Highlights
Market Cap: $0.00B indicates the company is a microcap stock.
- P/E Ratio: -0.00 reflecting that the company is currently not profitable.
- Profit Margin: 1181.3% suggests potential profitability if revenue increases.
- Gross Margin: -96.0% indicates significant cost of goods sold relative to revenue.
- Beta: -0.81 suggests the stock is less volatile than the market.
Who Are EDXC's Competitors?
EDXC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CYDX CYduct Diagnostics, Inc. | $1.24 | 0.00% | $6.50M | — |
| AVCNF Avicanna Inc. | $0.08 | 0.00% | $10.6M | 529-signal |
| PLNH Planet 13 Holdings Inc. | $0.13 | -7.14% | $42.7M | 429-signal |
| DBCCF Decibel Cannabis Company Inc. | $1.27 | -3.39% | $49.0M | 459-signal |
| ZYBT Zhengye Biotechnology Holding Limited | $1.59 | +1.27% | $75.4M | 465-pillar |
| CWBHF Charlotte's Web Holdings, Inc. | $0.35 | +6.23% | $93.9M | 519-signal |
| AAWH Ascend Wellness Holdings, Inc. | $0.49 | +1.36% | $98.7M | 439-signal |
| BGM BGM Group Ltd. | $0.28 | +0.92% | $105M | 455-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are EDXC's Key Strengths?
Diverse product range including creams, oils, capsules, and pet products.
- Established e-commerce platform (cbdunlimited.com).
- Focus on the growing CBD health and wellness market.
- Hemp-derived health and beauty care products.
What Are EDXC's Weaknesses?
Small company size with only 10 employees.
- Negative gross margin (-96.0%).
- Limited brand recognition compared to larger competitors.
- Reliance on a single e-commerce platform and limited retail partnerships.
What Could Drive EDXC Stock Higher?
EDXC catalyst: Potential changes in CBD regulations at the state or federal level could significantly impact the company's market access and growth prospects.
- Increasing consumer awareness and acceptance of CBD products may drive higher demand and sales for Endexx's product line.
- Expansion of the company's distribution network through strategic partnerships with retailers and healthcare providers.
- Launch of new CBD-infused products targeting specific health and wellness needs.
- Optimization of the company's e-commerce platform to improve user experience and drive online sales.
What Are the Key Risks for EDXC?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger CBD companies with greater resources and brand recognition.
- Evolving and uncertain regulatory landscape could restrict the sale or marketing of CBD products.
- Negative publicity or health concerns related to CBD products could damage the company's reputation and sales.
- Limited financial resources and small company size may hinder the company's ability to compete effectively.
- Reliance on a single e-commerce platform and limited retail partnerships increases the company's vulnerability to market changes.
What Are the Growth Opportunities for EDXC?
- Expansion of Product Line: Endexx can grow by introducing new CBD-infused products targeting specific health and wellness needs. The market for specialized CBD products, such as those targeting sleep, anxiety, and pain management, is expanding rapidly. By investing in research and development to create innovative formulations, Endexx can attract new customers and increase revenue streams. This expansion could tap into a market projected to reach $20 billion by 2028.
- Strategic Partnerships: Forming partnerships with established retailers and healthcare providers can significantly expand Endexx's distribution network. Collaborating with pharmacies, wellness centers, and online marketplaces can provide access to a broader customer base. These partnerships can also enhance the company's credibility and brand recognition. The timeline for establishing such partnerships is ongoing, with potential benefits realized within the next 1-2 years.
- Geographic Expansion: Expanding into new geographic markets, both domestically and internationally, represents a significant growth opportunity. As CBD regulations evolve globally, Endexx can target regions with favorable regulatory environments and high consumer demand. This expansion requires careful market research and strategic planning to ensure successful market entry. The global CBD market is expected to grow substantially over the next five years, presenting a lucrative opportunity for Endexx.
- E-commerce Optimization: Enhancing the user experience and functionality of cbdunlimited.com can drive increased online sales. Improving website navigation, offering personalized product recommendations, and implementing targeted marketing campaigns can attract and retain customers. Investing in e-commerce optimization can lead to higher conversion rates and increased revenue. This is an ongoing process that can yield immediate and long-term benefits.
- Pet Product Innovation: Capitalizing on the growing market for CBD pet products can drive significant revenue growth. Developing new formulations and delivery methods specifically tailored to pets can attract pet owners seeking natural health solutions for their animals. This includes CBD-infused treats, oils, and topicals designed to address various pet health concerns. The pet CBD market is projected to reach $1 billion by 2027, offering a substantial opportunity for Endexx.
What Are EDXC's Competitive Advantages?
- Established e-commerce platform (cbdunlimited.com).
- Diverse range of CBD products for humans and pets.
- Focus on hemp-derived health and beauty care products.
- Distribution network through online and in-store retailers.
What Does EDXC Do?
Endexx Corporation, formerly known as CBD Unlimited, Inc., was rebranded in May 2020 and is dedicated to the manufacturing and sale of cannabidiol (CBD)-based products. Headquartered in Cave Creek, Arizona, the company targets the health and wellness market, providing a diverse range of products including CBD creams, oils, capsules, extracts, topicals, drinks, and chocolates. Endexx also caters to the pet market with specialized CBD products. The company distributes its products through its e-commerce platform, cbdunlimited.com, as well as through various online and in-store retailers. Endexx focuses on hemp-derived health and beauty care products designed to provide therapeutic relief from pain and inflammation for both humans and pets. The company aims to capitalize on the growing demand for CBD products in the health and wellness sector by offering a wide array of accessible and consumer-friendly options.
What Products and Services Does EDXC Offer?
- Manufactures CBD-based creams for pain relief.
- Produces CBD oils for general wellness.
- Creates CBD capsules for easy consumption.
- Offers CBD extracts for concentrated doses.
- Develops CBD topicals for localized application.
- Sells CBD-infused drinks and chocolates.
- Provides CBD products specifically for pets.
- Distributes hemp-derived health and beauty care products.
How Does EDXC Make Money?
- Manufacturing and selling CBD-based products.
- Distribution through e-commerce platform cbdunlimited.com.
- Partnerships with online and in-store retailers.
- Focus on therapeutic relief of pain and inflammation for humans and pets.
What Industry Does EDXC Operate In?
Endexx Corporation operates within the rapidly expanding CBD health and wellness market. This market is characterized by increasing consumer demand for natural health solutions and a growing acceptance of CBD products. The competitive landscape includes numerous players, ranging from large pharmaceutical companies to smaller, specialized CBD manufacturers. Endexx aims to differentiate itself through its diverse product range and multi-channel distribution strategy. The industry faces ongoing regulatory challenges and evolving consumer preferences.
Who Are EDXC's Key Customers?
- Individuals seeking natural health and wellness solutions.
- Pet owners looking for CBD products for their pets.
- Retailers offering CBD products to their customers.
- Consumers interested in alternative pain relief methods.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 529 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 36 |
| 2026-08-26 | 36 |
| 2026-08-29 | 36 |
| 2026-09-01 | 36 |
| 2026-09-04 | 36 |
| 2026-09-07 | 36 |
| 2026-09-10 | 36 |
What changed?
The score has stayed at 36.
Over the same 18 days the stock moved +0.0%.
Company Profile
Endexx Corporation operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Cave Creek, US. The company is led by CEO Brad Listermann. EDXC has traded publicly since 2001.
EDXC Revenue & Earnings Trend
In Q2 FY2025, EDXC generated $0 in top-line revenue, marking a sequential decrease of 100.0%. The company recorded a net loss of $11.9M, with diluted EPS of $-0.02. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Healthcare. Across the four most recent quarters, EDXC averaged $-0.01 in diluted EPS.
Key Financial Metrics
Return on equity for Endexx Corporation stands at 18.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -29.8%, showing how much profit it generates from its asset base. A current ratio of 0.05 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Endexx Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
EDXC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Diverse product range including creams, oils, capsules, and pet products.
- Established e-commerce platform (cbdunlimited.com).
- Focus on the growing CBD health and wellness market.
- Hemp-derived health and beauty care products.
Bear Case
- Small company size with only 10 employees.
- Negative gross margin (-96.0%).
- Limited brand recognition compared to larger competitors.
- Reliance on a single e-commerce platform and limited retail partnerships.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2025 | $0 | -$12M | -$0.02 |
| Q1 FY2025 | $632,422 | -$45,502 | -$0.0001 |
| Q4 FY2024 | -$2M | -$45,576 | -$0.0001 |
| Q3 FY2024 | $25,500 | -$741,220 | -$0.0014 |
Q2 FY2025 · filed 31 Mar 2025 · SEC EDGAR →
Based on FMP financials and quantitative analysis
EDXC Latest News
-
Cannabis Stock Gainers And Losers From August 16, 2023
benzinga · Aug 16, 2023
-
Marijuana Stock Movers For August 15, 2023
benzinga · Aug 15, 2023
-
Cannabis Stock Gainers And Losers From August 14, 2023
benzinga · Aug 14, 2023
-
Cannabis Stock Gainers And Losers From August 4, 2023
benzinga · Aug 4, 2023
EDXC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EDXC.
Price Targets
Wall Street price target analysis for EDXC.
EDXC MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EDXC; grades run from A+ (80-100) to F (below 30).
Latest News
Leadership: Todd A. Davis
CEO
Todd A. Davis serves as the CEO of Endexx Corporation, managing a team of 10 employees. His background includes experience in the health and wellness sector, with a focus on developing and marketing innovative products. He has a track record of leading small teams and driving growth through strategic partnerships and product development. Davis is committed to expanding Endexx's presence in the CBD market and delivering high-quality products to consumers.
Track Record: Under Todd A. Davis's leadership, Endexx Corporation has focused on expanding its product line and distribution network. Key achievements include the rebranding of the company in May 2020 and the ongoing development of new CBD-infused products. Davis has also focused on strengthening the company's e-commerce platform and building relationships with key retailers.
EDXC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Endexx Corporation may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and greater volatility.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in EDXC.
- Low trading volume and wide bid-ask spreads can lead to price volatility.
- OTC Other tier companies are subject to less regulatory oversight.
- Potential for fraud or manipulation is higher on the OTC market.
- Liquidity risk may make it difficult to exit the investment.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Company has an operational e-commerce website (cbdunlimited.com).
- Company manufactures and sells CBD-based products.
- Company has been in operation since at least 2020 (rebranded from CBD Unlimited, Inc.).
- Company has a CEO and management team.
- Company is headquartered in the United States.
Common Questions About EDXC (Healthcare)
Is EDXC a good stock?
Stock Expert AI does not rate EDXC buy, sell or hold. Endexx Corporation has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about EDXC stock?
As of 2026-03-16, there is no readily available analyst coverage for Endexx Corporation (EDXC). Given its OTC listing and microcap status, the stock may not be widely followed by analysts.
What are the key factors to evaluate for EDXC?
Evaluate EDXC on fundamentals, analyst consensus, and risk factors. Key value drivers include expanding its product line and increasing its distribution network. Not financial advice.
How frequently does EDXC data refresh on this page?
EDXC's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven EDXC's recent stock price performance?
Endexx Corporation (EDXC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product range including creams, oils, capsules, and pet products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EDXC overvalued or undervalued right now?
Endexx Corporation (EDXC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of EDXC?
Yes, most major brokerages offer fractional shares of Endexx Corporation (EDXC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EDXC's earnings and financial reports?
Endexx Corporation (EDXC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for EDXC earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data may be outdated or incomplete.